期刊
CYTOMETRY PART B-CLINICAL CYTOMETRY
卷 92, 期 6, 页码 534-540出版社
WILEY
DOI: 10.1002/cyto.b.21374
关键词
H2AX; gamma-H2AX; DNA double-strand break (DSB); flow cytometry (FCM); ionizing radiation (IR); drug sensitivity; intrinsic radiation sensitivity; ataxia telangiectasia (AT)
资金
- Swedish Cancer Society (CF)
- Swedish Heart and Lung Foundation
- Swedish Pain Foundation (SSF)
- Assar Gabrielsson's Cancer Research Foundation
- LUA/ALF Funding at the Sahlgrenska University Hospital
- Swedish Research Council (Vetenskapsradet)
Background: The nucleosomal histone protein H2AX is specifically phosphorylated (gamma-H2AX) adjacent to DNA double-strand breaks (DSBs) and is used for quantifying DSBs. Many chemotherapies and ionizing radiation (IR) used in cancer treatment result in DSBs. Therefore, gamma-H2AX has a significant potential as a biomarker in evaluating patient sensitivity and responsiveness to IR and chemotherapy. Methods: Here, we report a flow cytometry-based quantification of gamma-H2AX (FCM-gamma-H2AX assay) customized for clinical practice. Results: We validated that our method is able to detect DNA damage in peripheral blood mononuclear cells (PBMCs) treated with DSB inducing agents. The method also detected the DNA repair deficiency in PBMCs treated with DNA repair inhibitors, as well as the deficiency in DNA repair signaling in PBMCs from two ataxia telangiectasia patients. Conclusions: The FCM-gamma-H2AX assay has sufficient analytical sensitivity and precision to measure levels of DNA damage and DNA repair for clinical purposes. (C) 2016 International Clinical Cytometry Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据